ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Multi-platform omics analysis reveals molecular signature for COVID-19 pathogenesis, prognosis and drug target discovery

Li, Yuming; Hou, Guixue; Zhou, Haibo; Wang, Yanqun; Tun, Hein Min; Zhu, Airu; Zhao, Jingxian; Xiao, Fei; Lin, Shanwen; Liu, Dongdong; Zhou, Dunrong; Mai, Lang; Zhang, Lu; Zhang, Zhaoyong; Kuang, Lijun; Guan, Jiao; Chen, Qiushi; Wen, Liyan; Zhang, Yanjun; Zhuo, Jianfen; Li, Fang; Zhuang, Zhen; Chen, Zhao; Luo, Ling; Liu, Donglan; Chen, Chunke; Gan, Mian; Zhong, Nanshan; Zhao, Jincun*; Ren, Yan*; Xu, Yonghao*广州医学院; 中山大学; 深圳华大基因研究院; 6; 1; 5; y
Signal Transduction and Targeted Therapy2021-4-15DOI: 10.1038/s41392-021-00508-4
45被引6阅读
引用收藏
分享

摘要

Disease progression prediction and therapeutic drug target discovery for Coronavirus disease 2019 (COVID-19) are particularly important, as there is still no effective strategy for severe COVID-19 patient treatment. Herein, we performed multi-platform omics analysis of serial plasma and urine samples collected from patients during the course of COVID-19. Integrative analyses of these omics data revealed several potential therapeutic targets, such as ANXA1 and CLEC3B. Molecular changes in plasma indicated dysregulation of macrophage and suppression of T cell functions in severe patients compared to those in non-severe patients. Further, we chose 25 important molecular signatures as potential biomarkers for the prediction of disease severity. The prediction power was validated using corresponding urine samples and plasma samples from new COVID-19 patient cohort, with AUC reached to 0.904 and 0.988, respectively. In conclusion, our omics data proposed not only potential therapeutic targets, but also biomarkers for understanding the pathogenesis of severe COVID-19.

学科与关键词

关键词
DISEASE
相关
加载中…
  • Metabolite, protein, and tissue dysfunction associated with COVID-19 disease severity
    Rahnavard, Ali*; Mann, Brendan; Giri, Abhigya; Chatterjee, Ranojoy; Crandall, Keith A.Scientific Reports, 2022, 12(1): 12204.被引 20
  • The role of multi-omics in the diagnosis of COVID-19 and the prediction of new therapeutic targets
    Ma, Jianli; Deng, Yuwei; Zhang, Minghui*; Yu, Jinming*Virulence, 2022, 13(1): 1101-1110.被引 6
  • The trans-omics landscape of COVID-19
    Wu, Peng; Chen, Dongsheng; Ding, Wencheng; Wu, Ping; Hou, Hongyan; Bai, Yong; Zhou, Yuwen; Li, Kezhen; Xiang, Shunian; Liu, Panhong; Ju, Jia; Guo, Ensong; Liu, Jia; Yang, Bin; Fan, Junpeng; He, Liang; Sun, Ziyong; Feng, Ling; Wang, Jian; Wu, Tangchun; Wang, Hao; Cheng, Jin; Xing, Hui; Meng, Yifan; Li, Yongsheng; Zhang, Yuanliang; Luo, Hongbo; Xie, Gang; Lan, Xianmei; Tao, Ye; Li, Jiafeng; Yuan, Hao; Huang, Kang; Sun, Wan; Qian, Xiaobo; Li, Zhichao; Huang, Mingxi; Ding, Peiwen; Wang, HaoyuNature Communications, 2021, 12(1): 4543.被引 58
查看全部 →

发表信息

论文状态
公开发表
期刊
Signal Transduction and Targeted Therapy
发表日期
2021-04-15
卷期
第 6 卷, 第 1 期
页码
155
DOI
10.1038/s41392-021-00508-4
期刊收录
NSL.CSCD-C.CAST-L
期刊等级
1区
成果收录
SCIE
资助标注
National Key Research and Development Program of China [2018YFC1200100]; National Science and Technology Major Project [2018ZX10301403]; emergency grants for prevention and control of SARS-CoV-2 of Ministry of Science and Technology of Guangdong province [2020A111128008, 2020B111112003, 2018B020207013, 2020B111108001, 2020B1111320003, 2020B1111330001]; National Program on Key Basic Research Project [2017YFC0906702]; National Key Technology RD Program [2018YFC1311900]; Guangdong Science and Technology Foundation [2019B030316028, 2020A1515010911]; Guangzhou Medical University High-level University Innovation Team Training Program (Guangzhou Medical University released [2017]) [159]; 111 project [D18010]

作者

  • L

    Li, Yuming (第一作者)

    1 · guangzhou med univ

  • H

    Hou, Guixue

    bgi shenzhen

查看全部 31 位作者收起作者
  • Z

    Zhou, Haibo

    6 · guangzhou med univ

  • W

    Wang, Yanqun

    1 · guangzhou med univ

  • T

    Tun, Hein Min

    hku · univ hong kong

  • Z

    Zhu, Airu

    1 · guangzhou med univ

  • Z

    Zhao, Jingxian

    1 · guangzhou med univ

  • X

    Xiao, Fei

    5 · sun yat sen univ

  • L

    Lin, Shanwen

  • L

    Liu, Dongdong

  • Z

    Zhou, Dunrong

  • M

    Mai, Lang

  • Z

    Zhang, Lu

    guangzhou med univ

  • Z

    Zhang, Zhaoyong

    1 · guangzhou med univ

  • K

    Kuang, Lijun

    1 · guangzhou med univ

  • G

    Guan, Jiao

    bgi shenzhen

  • C

    Chen, Qiushi

    bgi shenzhen

  • W

    Wen, Liyan

    1 · guangzhou med univ

  • Z

    Zhang, Yanjun

    1 · guangzhou med univ

  • Z

    Zhuo, Jianfen

    1 · guangzhou med univ

  • L

    Li, Fang

    1 · guangzhou med univ

  • Z

    Zhuang, Zhen

    1 · guangzhou med univ

  • C

    Chen, Zhao

    1 · guangzhou med univ

  • L

    Luo, Ling

    1 · guangzhou med univ

  • L

    Liu, Donglan

  • C

    Chen, Chunke

    1 · guangzhou med univ

  • G

    Gan, Mian

    1 · guangzhou med univ

  • Z

    Zhong, Nanshan

    1 · guangzhou med univ

  • Z

    Zhao, Jincun (通讯)

    guangzhou med univ · 1

  • R

    Ren, Yan (通讯)

    bgi shenzhen

  • X

    Xu, Yonghao (通讯)

    1 · guangzhou med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417